BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$85.31 USD
+1.22 (1.45%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $85.31 0.00 (0.00%) 4:32 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
BioMarin Pharmaceutical Inc. [BMRN]
Reports for Purchase
Showing records 781 - 800 ( 818 total )
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Kuvan Highlighted in Presentations at ACMG Medical Conference
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
4Q10 and FY10 Financial Results in Line-Introducing Adjusted EBITDA
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: BERNARDINO V
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials: Annual Growth Intact Despite Quarterly Choppiness
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of February 6
Provider: WEDBUSH SECURITIES INC.
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Next Wave of Pipeline Products Enter Clinic
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: BERNARDINO V
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
LIFE SCIENCES -The Week Ahead in Life Sciences - Upcoming Events for the Week of January 16
Provider: WEDBUSH SECURITIES INC.
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
2011 Major Value Drivers in Emerging Pharmaceuticals.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
BMN 673 Approved For Clinical Trial Testing In The UK
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
Company: BioMarin Pharmaceutical Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.